Prostatic Urethral Articles & Analysis
4 news found
Prostatitis is a disease characterized by the presence of inflammation and/or infection localized in the prostate gland. ...
Medeon Biodesign, Inc. (TPEx: 6499), a Taiwan publicly traded medical device company, is pleased to announce positive interim results of the EXPANDER-1 Clinical Study for its flagship product the XFLO™ Expander System, an innovative, minimally invasive Benign Prostatic Hyperplasia (BPH) treatment solution. XFLO offers a reversible and office-based treatment option for patients who are ...
Zenflow, Inc., a medical device company developing a minimally invasive treatment for enlarged prostate, or benign prostatic hyperplasia (BPH), has initiated the BREEZE™ pivotal clinical trial to evaluate its Spring System. ...
” He continued, “This unique technology was designed to reduce urinary symptoms by reshaping the prostatic urethra. The clinical data is likewise pleasing and justifies moving this technology into randomized controlled ...